236 related articles for article (PubMed ID: 27923447)
1. Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice.
Bae JS; Park JM; Lee J; Oh BC; Jang SH; Lee YB; Han YM; Ock CY; Cha JY; Hahm KB
Metabolism; 2017 Jan; 66():32-44. PubMed ID: 27923447
[TBL] [Abstract][Full Text] [Related]
2. Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease.
Kim EH; Bae JS; Hahm KB; Cha JY
Biochem Pharmacol; 2012 Nov; 84(10):1359-65. PubMed ID: 22981383
[TBL] [Abstract][Full Text] [Related]
3. Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter.
Cha JY; Park JM; Lee HJ; Bae JS; Han YM; Oh BC; Ko KH; Hahm KB
Curr Pharm Des; 2017; 23(27):3941-3951. PubMed ID: 28714405
[TBL] [Abstract][Full Text] [Related]
4. The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.
Šmíd V; Dvořák K; Stehnová K; Strnad H; Rubert J; Stříteský J; Staňková B; Stránská M; Hajšlová J; Brůha R; Vítek L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139055
[TBL] [Abstract][Full Text] [Related]
5. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet.
Toyoda Y; Takada T; Yamanashi Y; Suzuki H
Lipids Health Dis; 2019 Dec; 18(1):234. PubMed ID: 31883528
[TBL] [Abstract][Full Text] [Related]
7. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
Guo XF; Gao JL; Li JM; Li D
Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610
[TBL] [Abstract][Full Text] [Related]
8. Cox-2 expression, PGE(2) and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice.
Gravaghi C; La Perle KM; Ogrodwski P; Kang JX; Quimby F; Lipkin M; Lamprecht SA
J Nutr Biochem; 2011 Apr; 22(4):360-5. PubMed ID: 20655721
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 Polyunsaturated Fatty Acids Attenuate Fibroblast Activation and Kidney Fibrosis Involving MTORC2 Signaling Suppression.
Zeng Z; Yang H; Wang Y; Ren J; Dai Y; Dai C
Sci Rep; 2017 Apr; 7():46146. PubMed ID: 28393852
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Pancreatic Carcinoma Growth Through Enhancing ω-3 Epoxy Polyunsaturated Fatty Acid Profile by Inhibition of Soluble Epoxide Hydrolase.
Xia R; Sun L; Liao J; Li H; You X; Xu D; Yang J; Hwang SH; Jones RD; Hammock B; Yang GY
Anticancer Res; 2019 Jul; 39(7):3651-3660. PubMed ID: 31262891
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs.
Bae JS; Oh AR; Cha JY
J Lifestyle Med; 2013 Mar; 3(1):19-25. PubMed ID: 26064833
[TBL] [Abstract][Full Text] [Related]
12. High Endogenous Accumulation of ω-3 Polyunsaturated Fatty Acids Protect against Ischemia-Reperfusion Renal Injury through AMPK-Mediated Autophagy in Fat-1 Mice.
Gwon DH; Hwang TW; Ro JY; Kang YJ; Jeong JY; Kim DK; Lim K; Kim DW; Choi DE; Kim JJ
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28974016
[TBL] [Abstract][Full Text] [Related]
13. The generation of transgenic mice with fat1 and fad2 genes that have their own polyunsaturated fatty acid biosynthetic pathway.
Chen Y; Mei M; Zhang P; Ma K; Song G; Ma X; Zhao T; Tang B; Ouyang H; Li G; Li Z
Cell Physiol Biochem; 2013; 32(3):523-32. PubMed ID: 24008613
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Niemann-Pick C1-Like 1 exacerbates non-alcoholic fatty liver disease by re-absorbing specific biliary oxysterols.
Yamanashi Y; Takada T; Tanaka Y; Ogata Y; Toyoda Y; Ito SM; Kitani M; Oshida N; Okada K; Shoda J; Suzuki H
Biomed Pharmacother; 2022 Dec; 156():113877. PubMed ID: 36270257
[TBL] [Abstract][Full Text] [Related]
15. Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis.
Huang W; Wang B; Li X; Kang JX
Biofactors; 2015; 41(6):453-62. PubMed ID: 26637972
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids.
de Castro GS; Calder PC
Clin Nutr; 2018 Feb; 37(1):37-55. PubMed ID: 28139281
[TBL] [Abstract][Full Text] [Related]
17. Elevated tissue omega-3 fatty acid status prevents age-related glucose intolerance in fat-1 transgenic mice.
Romanatto T; Fiamoncini J; Wang B; Curi R; Kang JX
Biochim Biophys Acta; 2014 Feb; 1842(2):186-91. PubMed ID: 24211484
[TBL] [Abstract][Full Text] [Related]
18. Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids.
Alvaro A; Rosales R; Masana L; Vallvé JC
J Nutr Biochem; 2010 Jun; 21(6):518-25. PubMed ID: 19443194
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
20. n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD.
Vauzour D; Rodriguez-Ramiro I; Rushbrook S; Ipharraguerre IR; Bevan D; Davies S; Tejera N; Mena P; de Pascual-Teresa S; Del Rio D; Gavrilovic J; Minihane AM
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):69-78. PubMed ID: 28986308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
